2 Top Biotech Stocks Ready for a Bull Run
The stock market has been on a fantastic run since late March 2020, with the S&P 500 more than doubling since then. Perhaps your portfolio has performed on par with the broader market, or maybe it hasn't.
Whether you want to maintain your momentum or turn things around, two exciting biotech stocks that could help supercharge your portfolio are Novavax (NASDAQ: NVAX) and Axsome Therapeutics (NASDAQ: AXSM). Here's why.
Small-cap biotech Axsome Therapeutics has had a rough year, largely due to regulatory setbacks. Perhaps the most damaging was the delay the company's application for AXS-05 encountered. AXS-05, a potential treatment for major depressive disorder, could have been on the market already, as the U.S. Food and Drug Administration (FDA) had initially set a PDUFA goal date (PDUFA stands for Prescription Drug User Fee Act, the date is the latest date to complete the review) of Aug. 22.
Source Fool.com
